Skip to content

To Study the effect of Dhatryadi Eye Drops in Cataract

Randomized Controlled Clinical Study to Assess Effect Of Dhatryadi Eye Drops In Immature Senile Cataract - -

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034262
Enrollment
100
Registered
2021-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

Intervention1: Dhatryadi eye drops: Dhatri saindhav pippali marich Honey 2 drops bid, duration one month Control Intervention1: NA: NA Control Intervention2: Catagon eye drops: Nacl kcl 2 drops bid du

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having sign and symptoms of immature senile cataract.

Exclusion criteria

Exclusion criteria: KNOWN CASE OF DIABETES PATIENTS WITH EXTRAOCULAR OR INTRAOCUIAR DISEASES

Design outcomes

Primary

MeasureTime frame
TO evaluate effect of Dhatryadi eye drops in immature senile cataractTimepoint: 2 years

Secondary

MeasureTime frame
To evaluate effect of Dhatryadi eye drops in immature senile cataract To study the adverse effect of dhatryadi eye drops To find out cost effectiveness of treatment To study beneficial effect of ancient mode of treatment in modern eraTimepoint: 1st 7th 15th 30th day for trial medication & observations Total study Duration is of 2 years;whether dhatryadi rasakriya eye drop will remain sterile after 30 daysTimepoint: To evaluate sterility of preservative free dhatryadi eye drops after 30 days

Countries

India

Contacts

Public ContactDr Anantrao Shankarrao Bangar

Yashwant Ayurved Mahavidyalaya kodoli

drcnm05@gmail.com9175800710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026